Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 204 | 135 | 30 | 0 | 30 |
| Gross Profit | 204 | 135 | 30 | N/A | 30 |
| Operating Expenses | 8,144 | 4,588 | 1,636 | 0 | 808 |
| Operating Income | -7,940 | -4,453 | -1,606 | N/A | -778 |
| Interest Expense | 0 | 4 | 14 | 0 | 28 |
| Other Income | -316 | -637 | -43 | 0 | -7 |
| Pre-tax Income | -8,256 | -5,094 | -1,663 | 0 | -813 |
| Net Income Continuous | -8,256 | -5,094 | -1,663 | N/A | -813 |
| Net Income | $-8,256 | $-5,094 | $-1,663 | $N/A | $-813 |
| EPS Basic Total Ops | -5.00 | -22.70 | -4.50 | N/A | -2.20 |
| EPS Basic Continuous Ops | -5.04 | -13.87 | -4.53 | N/A | -2.21 |
| EPS Diluted Total Ops | -5.00 | -22.70 | -4.50 | N/A | -2.20 |
| EPS Diluted Continuous Ops | -5.04 | -13.87 | -4.53 | N/A | -2.21 |
| EBITDA(a) | $-7,891 | $-4,428 | $-1,597 | $N/A | $-766 |